Jennison Associates
BNTX icon

Jennison Associates’s BioNTech BNTX Stock Holding History

Jennison Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-185,818
Closed -$31.7M – 626
2022
Q1 		$31.7M Sell
185,818
-2,940,921
-94% -$494M 0.02% 288
2021
Q4 		$806M Sell
3,126,739
-946,831
-23% -$259M 0.51% 43
2021
Q3 		$1.11B Buy
4,073,570
+3,814,715
+1,474% +$1.21B 0.72% 38
2021
Q2 		$58M Sell
258,855
-39,700
-13% -$7.49M 0.04% 196
2021
Q1 		$32.6M Buy
+298,555
New +$31.7M 0.02% 288

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Jennison Associates's BNTX Position: Q2 2022 in Review

Jennison Associates sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 185,818 shares — an estimated $31.7M sold.

Jennison Associates first reported a position in BNTX in Q1 2021 and held it in 5 quarters. The position peaked at $1.11B in Q3 2021. 292 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

  • Jennison Associates reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
  • Jennison Associates sold 185,818 BioNTech shares in Q2 2022, an estimated $31.7M.
  • Jennison Associates first reported a position in BioNTech in Q1 2021 and held it in 5 quarters.
  • Jennison Associates's BioNTech position peaked at $1.11B in Q3 2021.
  • 292 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.